Skip to Main Content
Table 2.

Adverse events

Grade 1Grade 2
# events (% doses)Patients (% of patients)# events (% doses)Patients (% of patients)
Likely/possibly related 
 Injection site reaction 48 (18) 24 (71) 8 (2) 7 (21) 
 Fever 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
 Flu-like symptoms 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
 Lymphocyte count decreased 4 (1.5) 2 (6) 2 (0.8) 2 (6) 
 Joint effusion/joint swelling 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
 Myalgias/body aches 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
 Pruritus 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
Grade 1Grade 2
# events (% doses)Patients (% of patients)# events (% doses)Patients (% of patients)
Likely/possibly related 
 Injection site reaction 48 (18) 24 (71) 8 (2) 7 (21) 
 Fever 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
 Flu-like symptoms 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
 Lymphocyte count decreased 4 (1.5) 2 (6) 2 (0.8) 2 (6) 
 Joint effusion/joint swelling 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
 Myalgias/body aches 1 (0.4) 1 (2.9) 0 (0) 0 (0) 
 Pruritus 1 (0.4) 1 (2.9) 0 (0) 0 (0) 

NOTE: Calculation based on 266 administered doses. No events higher than grade 2 attributed to vaccine.

Close Modal

or Create an Account

Close Modal
Close Modal